Safety and Efficacy of Fecal Microbiota, Live-jslm to Prevent Recurrent Clostridioides difficile Infection in Participants With Irritable Bowel Syndrome
Safety and Efficacy of Fecal Microbiota, Live-jslm to Prevent Recurrent Clostridioides difficile Infection in Participants With Irritable Bowel Syndrome
Shubhi Srivastava, H. Christian Weber, Beth Guthmueller, Anthony J Lembo et al.
Citations
1 citations
Journal
Infectious Diseases and Therapy
Topics
Gastrointestinal motility and disorders
Field-Weighted Citation Impact (FWCI)
1.81
article
Safety and Efficacy of Fecal Microbiota, Live-jslm to Prevent Recurrent Clostridioides difficile Infection in Participants With Irritable Bowel Syndrome
Shubhi Srivastava, H. Christian Weber, Beth Guthmueller, Anthony J Lembo, Olga C. Aroniadis, Paul Feuerstadt, Kaitlin Dehlin
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Infectious Diseases and TherapyVol. 14(9)
Institutions
Boston University (US), Cleveland Clinic (US), Yale University (US), Stony Brook School (US), Ferring Pharmaceuticals (United States) (US), Ferring Pharmaceuticals (Denmark) (DK)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Safety and Efficacy of Fecal Microbiota, Live-jslm to Prevent Recurrent Clostridioides difficile Infection in Participants With Irritable Bowel Syndrome — Shubhi Srivastava, H. Christian Weber, et al. · Infectious Diseases and Therapy (2025) | TGRS Research Map | TGRS